15-Sept-2026 18:13:35

AUROBINDO PHARMA LIMITED : COMPLETION OF US FDA INSPECTION AT UNIT-II

• Apitoria Pharma Private Limited, a wholly owned subsidiary, was inspected by US FDA at its Unit-II API manufacturing facility. • The inspection took place from September 7th to September 15th, 2026. • The inspection concluded with one observation, which is procedural in nature. • The company will respond to the US FDA within the stipulated timeline.

Aurobindo Pharma Limited

← Back to feed